The document is a table listing transplantations of umbilical cord blood from private cord blood banks for standard hematopoietic stem cell transplants. It lists the disease treated, the donor type (autologous or sibling), the year, hospital, and cord blood bank. Many of the transplants listed were used to treat acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, and aplastic anemia. The table provides details on over 150 transplantations dating back to 1993 and involving hospitals in countries around the world.
Extending the Life of Platelets & Protecting the Lives of Patients at WellSpa...Charles J. DiComo, PhD
Like many health systems, WellSpan Health experienced frequent fluctuations in demand for platelet transfusions. Sudden increases required emergency shipments, while decreases led to waste. Lab leadership needed an easier way to ensure the availability of safe platelet transfusions at all times.
The Pennsylvania-based integrated health system implemented
the Platelet PGD test in 2016 at its largest acute care facility,
WellSpan York Hospital. The testing enables the hospital to extend platelets to day six or seven by PGD testing for bacterial contamination. In turn, this extended dating allows the hospital
to stabilize inventory and generate cost savings by significantly
reducing wastage.
Total Pregnancy Care is an online guide for pregnancy, childbirth and motherhood related information. Women wanting to conceive, pregnant women, expecting parents, and new mothers can use this pregnancy portal for a healthy pregnancy, fulfilling childbirth and joyful motherhood. With pregnancy at its core, this portal covers various important aspects and especially addresses those matters that the Indian Woman always wanted to know but did not know whom to ask. Visit www.totalpregnancycare.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Extending the Life of Platelets & Protecting the Lives of Patients at WellSpa...Charles J. DiComo, PhD
Like many health systems, WellSpan Health experienced frequent fluctuations in demand for platelet transfusions. Sudden increases required emergency shipments, while decreases led to waste. Lab leadership needed an easier way to ensure the availability of safe platelet transfusions at all times.
The Pennsylvania-based integrated health system implemented
the Platelet PGD test in 2016 at its largest acute care facility,
WellSpan York Hospital. The testing enables the hospital to extend platelets to day six or seven by PGD testing for bacterial contamination. In turn, this extended dating allows the hospital
to stabilize inventory and generate cost savings by significantly
reducing wastage.
Total Pregnancy Care is an online guide for pregnancy, childbirth and motherhood related information. Women wanting to conceive, pregnant women, expecting parents, and new mothers can use this pregnancy portal for a healthy pregnancy, fulfilling childbirth and joyful motherhood. With pregnancy at its core, this portal covers various important aspects and especially addresses those matters that the Indian Woman always wanted to know but did not know whom to ask. Visit www.totalpregnancycare.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
1. tabulka_A_2print 1.pdf 8/9/11 12:24:06 PM
Pupečníková krev použitá
pro autologní a sourozenecké transplantace
z rodinných bank pupečníkové krve
Rodinné banky na pupečníkovou krev uchovávají pupečníkovou krev za účelem transplantace krvetvorných kmenových buněk. Při léčbě
hematologických, onkologických nebo genetických onemocnění se transplantační lékaři čím dál častěji rozhodují ve prospěch používání
pupečníkové krve uložené v soukromých bankách pro autologní nebo sourozenecké transplantace. Následující tabulka obsahuje zveřejněné
informace o použití pupečníkové krve ze soukromých bank pro standardní transplantace krvetvorných kmenových buněk.
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Akutní lymfoblastová leukémie
Autologní 2004 Oak Lawn Hospital, IL, USA VITA 34
Sourozenec 1996 University Medical Center, Tucson, USA CBR
Sourozenec 1996 University of Miami, Miami, USA ViaCord
Sourozenec 1997 Children’s Hospital Los Angeles, Los Angeles, USA CBR
C
Sourozenec 1998 Kaiser Hospital Los Angeles, Los Angeles, USA CBR
M
Sourozenec 1999 University Medical Center, Tucson, USA CBR
Y
Sourozenec 2000 Devos Children’s Hospital, Grand Rapids, USA CBR
CM
Sourozenec 2000 Children’s Hospital of Wisconsin, Milwaukee, USA CBR
MY Sourozenec 2001 University Medical Center, Tucson, USA CBR
CY Sourozenec 2001 Children’s Hospital of Pennsylvania, Philadelphia, USA CBR
CMY Sourozenec 2001 Hospital for Sick Children, Toronto, Kanada Insception Biosciences
K Sourozenec 2001 Johns Hopkins University, Baltimore, USA ViaCord
Sourozenec 2002 City of Hope, Duarte, USA CBR
Sourozenec 2002 City of Hope, Duarte, USA CBR
Sourozenec 2002 Children’s Hospital San Diego, San Diego, USA CBR
Sourozenec 2002 Children’s Hospital Los Angeles, Los Angeles, USA CBR
Sourozenec 2002 Johns Hopkins University, Baltimore, USA ViaCord
Sourozenec 2002 Lucile Packard Children's Hospital, Palo Alto, USA ViaCord
Sourozenec 2003 Uni of Michigan, Michigan, USA Cryo–Cell
Sourozenec 2003 Vanderbilt Medical Center, Nashville, USA CBR
Sourozenec 2003 Hackensack University Medical Center, USA CBR
Sourozenec 2003 Hospital for Sick Children, Toronto, Canada Insception Biosciences
Sourozenec 2003 Oregon Health & Science University, Portland, USA ViaCord
Sourozenec 2003 Oregon Health & Science University, Portland, USA ViaCord
Sourozenec 2003 Riley Hospital for Children, Indianapolis, USA ViaCord
Sourozenec 2003 Cincinnati Children's Hospital, Cincinnati, USA ViaCord
Sourozenec 2003 Fred Hutchinson Cancer Research Center, Seattle, USA ViaCord
Sourozenec 2003 Children's Hospital, Denver, USA ViaCord
Sourozenec 2004 Ruiz Arguelles Clinic Cryo–Cell
Sourozenec 2004 Cook Children’s Medical Center, Ft. Worth, USA CBR
Sourozenec 2004 University Medical Center, Tucson, USA CBR
www.cordbloodcenter.cz
1
2. tabulka_A_2print 2-3.pdf 8/9/11 12:25:45 PM
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Akutní lymfoblastová leukémie/pokr. Akutní myeloidní leukémie/pokr.
Sourozenec 2004 Shands University of Florida, Gainesville, USA CBR Sourozenec 2007 Children’s Hospital of Boston, Boston, USA CBR
Sourozenec 2005 UC Davis Medical Center, Sacramento, USA ViaCord Sourozenec 2007 Westchester Medical Center, Valhalla, USA CBR
Sourozenec 2006 Hospital 20 de Noviembre ISSTE, Mexiko Cryo–Cell Sourozenec 2008 All Children's Hospital, St. Petersburg, USA ViaCord
Sourozenec 2006 Kapi'olani Medical Center, Honolulu, USA ViaCord Sourozenec 2008 All Children’s Hospital, St. Petersburg, USA CBR
Sourozenec 2006 Shands University of Florida, Gainesville,USA ViaCord Sourozenec 2008 Hospital Juan I. Menchaca, Mexiko Cryo–Cell
Sourozenec 2006 Duke University, Durham, USA ViaCord Sourozenec 2008 UCSF Medical Center, San Francisco, USA CBR
Sourozenec 2007 Shands University of Florida, Gainesville, USA CBR Sourozenec 2008 University Medical Center, Tucson, USA CBR
Sourozenec 2007 University of Michigan, Ann Arbor, USA ViaCord Sourozenec 2009 Children's National Medical Center, Washington DC, USA ViaCord
Sourozenec 2007 University of North Carolina, Chapel Hill, USA ViaCord
Sourozenec 2007 Duke University, Durham, USA ViaCord Chronická myeloidní leukémie
Sourozenec 2007 Children's Memorial Hospital, Chicago, USA ViaCord Sourozenec 1993 University of Minnesota, Minneapolis, USA CBR
Sourozenec 2008 University Medical Center, Tucson, USA CBR Sourozenec 1999 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2008 Children’s Hospital of Wisconsin, Milwaukee, USA CBR Sourozenec 2008 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell
Sourozenec 2008 UCLA, Los Angeles, USA ViaCord
Sourozenec 2008 Dana–Farber Cancer Institute, Boston, USA ViaCord Aplastická anémie
C
Sourozenec 2008 Dana–Farber Cancer Institute, Boston, USA ViaCord Autologní 2001 Mount Sinai Medical Center, NY, USA ViaCord
Sourozenec 2009 EVROPA Cryo–Save
M
Autologní 2002 Cedars–Sinai Medical Center, LA, USA Cryo–Cell
Sourozenec 2009 Riley Children's Hospital, Indianapolis, USA ViaCord
Y
Autologní 2002 University of Minnesota, Minneapolis, USA CBR
Sourozenec 2009 City of Hope, Duarte,USA ViaCord
CM
Autologní 2004 Children´s Hospital,Seattle, USA CBR
MY
Sourozenec 2010 Cook Children’s Medical Center, Ft. Worth, USA CBR Autologní 2004 Universitaetsklinikum, Frankfurt, Německo Cryo–Save
CY
Sourozenec 2010 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Autologní 2006 City of Hope, Duarte, USA CBR
CMY
Sourozenec 2010 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Autologní 2006 City of Hope, Duarte, USA CBR
K
Sourozenec 2010 Cook Children's Medical Center, Fort Worth, Texas, USA ViaCord Autologní 2009 MD Anderson Cancer Center, Houston, USA ViaCord
Autologní 2010 Children's Hospital of Alabama, USA ViaCord
Akutní myeloidní leukémie Sourozenec 1997 Duke University, Durham, USA ViaCord
Sourozenec 1997 Rush University, Chicago, USA ViaCord Sourozenec 2000 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 1998 Lucile Packard Children’s Hospital, California, USA CBR Sourozenec 2001 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Sourozenec 2000 University of Minnesota, Minneapolis, USA ViaCord Sourozenec 2004 UC Davis Medical Center, Sacramento, USA CBR
Sourozenec 2001 City of Hope, Duarte, USA CBR Sourozenec 2005 Hannover, Germany Vita 34
Sourozenec 2002 Children's Hospital & Research Center, Oakland,USA ViaCord Sourozenec 2005 New York Medical College, Valhalla, USA ViaCord
Sourozenec 2002 Texas Transplant Institute, San Antonio, USA ViaCord Sourozenec 2006 Children’s Hospital of Wisconsin, Milwaukee, USA CBR
Sourozenec 2002 UCSF Medical Center, San Francisco, USA ViaCord Sourozenec 2007 Children's Hospital of Wisconsin, Milwaukee, USA ViaCord
Sourozenec 2002 University of Nebraska, Omaha, USA ViaCord Sourozenec 2007 University of Minnesota, Minneapolis, USA ViaCord
Sourozenec 2003 New York–Presbyterian Hospital, New York, USA ViaCord Sourozenec 2008 USA Cryo–Cell
Sourozenec 2004 Primary Children's Medical Center, Salt Lake City, USA ViaCord Sourozenec 2009 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2005 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell
Sourozenec 2005 Children's Hospital & Research Center, Oakland, USA ViaCord
Meduloblastom
Sourozenec 2005 University Medical Center, Tucson, USA ViaCord
Autologní 2004 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2006 All Children’s Hospital, St. Petersburg, USA CBR
Autologní 2007 Starship Childrens Hospital, Auckland, Nový Zéland CordBank
Sourozenec 2006 Riley Hospital for Children, Indianapolis, USA ViaCord
Autologní 2009 Centro De Transfusions de la Comunidad de Madrid, Španělsko Cryo–Save
Sourozenec 2006 UCLA, Los Angeles, USA ViaCord
Sourozenec 2007 Columbus Children's Hospital, Columbus, USA ViaCord
www.cordbloodcenter.cz www.cordbloodcenter.cz
2 3
3. tabulka_A_2print 2-3.pdf 8/9/11 12:25:45 PM
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Akutní lymfoblastová leukémie/pokr. Akutní myeloidní leukémie/pokr.
Sourozenec 2004 Shands University of Florida, Gainesville, USA CBR Sourozenec 2007 Children’s Hospital of Boston, Boston, USA CBR
Sourozenec 2005 UC Davis Medical Center, Sacramento, USA ViaCord Sourozenec 2007 Westchester Medical Center, Valhalla, USA CBR
Sourozenec 2006 Hospital 20 de Noviembre ISSTE, Mexiko Cryo–Cell Sourozenec 2008 All Children's Hospital, St. Petersburg, USA ViaCord
Sourozenec 2006 Kapi'olani Medical Center, Honolulu, USA ViaCord Sourozenec 2008 All Children’s Hospital, St. Petersburg, USA CBR
Sourozenec 2006 Shands University of Florida, Gainesville,USA ViaCord Sourozenec 2008 Hospital Juan I. Menchaca, Mexiko Cryo–Cell
Sourozenec 2006 Duke University, Durham, USA ViaCord Sourozenec 2008 UCSF Medical Center, San Francisco, USA CBR
Sourozenec 2007 Shands University of Florida, Gainesville, USA CBR Sourozenec 2008 University Medical Center, Tucson, USA CBR
Sourozenec 2007 University of Michigan, Ann Arbor, USA ViaCord Sourozenec 2009 Children's National Medical Center, Washington DC, USA ViaCord
Sourozenec 2007 University of North Carolina, Chapel Hill, USA ViaCord
Sourozenec 2007 Duke University, Durham, USA ViaCord Chronická myeloidní leukémie
Sourozenec 2007 Children's Memorial Hospital, Chicago, USA ViaCord Sourozenec 1993 University of Minnesota, Minneapolis, USA CBR
Sourozenec 2008 University Medical Center, Tucson, USA CBR Sourozenec 1999 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2008 Children’s Hospital of Wisconsin, Milwaukee, USA CBR Sourozenec 2008 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell
Sourozenec 2008 UCLA, Los Angeles, USA ViaCord
Sourozenec 2008 Dana–Farber Cancer Institute, Boston, USA ViaCord Aplastická anémie
C
Sourozenec 2008 Dana–Farber Cancer Institute, Boston, USA ViaCord Autologní 2001 Mount Sinai Medical Center, NY, USA ViaCord
Sourozenec 2009 EVROPA Cryo–Save
M
Autologní 2002 Cedars–Sinai Medical Center, LA, USA Cryo–Cell
Sourozenec 2009 Riley Children's Hospital, Indianapolis, USA ViaCord
Y
Autologní 2002 University of Minnesota, Minneapolis, USA CBR
Sourozenec 2009 City of Hope, Duarte,USA ViaCord
CM
Autologní 2004 Children´s Hospital,Seattle, USA CBR
MY
Sourozenec 2010 Cook Children’s Medical Center, Ft. Worth, USA CBR Autologní 2004 Universitaetsklinikum, Frankfurt, Německo Cryo–Save
CY
Sourozenec 2010 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Autologní 2006 City of Hope, Duarte, USA CBR
CMY
Sourozenec 2010 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Autologní 2006 City of Hope, Duarte, USA CBR
K
Sourozenec 2010 Cook Children's Medical Center, Fort Worth, Texas, USA ViaCord Autologní 2009 MD Anderson Cancer Center, Houston, USA ViaCord
Autologní 2010 Children's Hospital of Alabama, USA ViaCord
Akutní myeloidní leukémie Sourozenec 1997 Duke University, Durham, USA ViaCord
Sourozenec 1997 Rush University, Chicago, USA ViaCord Sourozenec 2000 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 1998 Lucile Packard Children’s Hospital, California, USA CBR Sourozenec 2001 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Sourozenec 2000 University of Minnesota, Minneapolis, USA ViaCord Sourozenec 2004 UC Davis Medical Center, Sacramento, USA CBR
Sourozenec 2001 City of Hope, Duarte, USA CBR Sourozenec 2005 Hannover, Germany Vita 34
Sourozenec 2002 Children's Hospital & Research Center, Oakland,USA ViaCord Sourozenec 2005 New York Medical College, Valhalla, USA ViaCord
Sourozenec 2002 Texas Transplant Institute, San Antonio, USA ViaCord Sourozenec 2006 Children’s Hospital of Wisconsin, Milwaukee, USA CBR
Sourozenec 2002 UCSF Medical Center, San Francisco, USA ViaCord Sourozenec 2007 Children's Hospital of Wisconsin, Milwaukee, USA ViaCord
Sourozenec 2002 University of Nebraska, Omaha, USA ViaCord Sourozenec 2007 University of Minnesota, Minneapolis, USA ViaCord
Sourozenec 2003 New York–Presbyterian Hospital, New York, USA ViaCord Sourozenec 2008 USA Cryo–Cell
Sourozenec 2004 Primary Children's Medical Center, Salt Lake City, USA ViaCord Sourozenec 2009 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2005 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell
Sourozenec 2005 Children's Hospital & Research Center, Oakland, USA ViaCord
Meduloblastom
Sourozenec 2005 University Medical Center, Tucson, USA ViaCord
Autologní 2004 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2006 All Children’s Hospital, St. Petersburg, USA CBR
Autologní 2007 Starship Childrens Hospital, Auckland, Nový Zéland CordBank
Sourozenec 2006 Riley Hospital for Children, Indianapolis, USA ViaCord
Autologní 2009 Centro De Transfusions de la Comunidad de Madrid, Španělsko Cryo–Save
Sourozenec 2006 UCLA, Los Angeles, USA ViaCord
Sourozenec 2007 Columbus Children's Hospital, Columbus, USA ViaCord
www.cordbloodcenter.cz www.cordbloodcenter.cz
2 3
4. tabulka_A_2print 4-5.pdf 8/9/11 12:28:22 PM
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Myelodysplastický syndrom Fanconiho anémie
Autologní 2009 Chi Mei Medical Center, Tchaj-wan Bionet Sourozenec 1999 Johns Hopkins Hospital, Baltimore, USA ViaCord
Autologní 2010 University of Erlangen, Erlangen, Německo ViaCord Sourozenec 1999 University Medical Center, Tucson, USA CBR
Sourozenec 1995 University Medical Center, Tucson, USA CBR Sourozenec 2002 University of Minnesota, Minneapolis, USA ViaCord
Sourozenec 1999 Oregon Health & Science University, Portland, USA ViaCord Sourozenec 2003 Cincinnati Children's Hospital, Cincinnati, USA ViaCord
Sourozenec 2003 University of Mississippi, Jackson, USA ViaCord Sourozenec 2004 Children’s Hospital San Diego, San Diego, USA CBR
Sourozenec 2006 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2005 Cincinnati Children's Hospital, Cincinnati, USA ViaCord
Sourozenec 2006 Children's Hospital of Philadelphia, Philadelphia, USA ViaCord Sourozenec 2009 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Neuroblastom Beta-talasemie
Autologní 1998 Albert Einstein Hospital, Sao Paulo, Brazílie Albert Einstein Hospital Sourozenec 1998 University of Chicago, Chicago, USA ViaCord
Autologní 2001 Texas Children´s Hospital, Houston, USA ViaCord Sourozenec 1998 UCSF Medical Center, San Francisco, USA ViaCord
Autologní 2006 Vanderbilt University Medical Center Nashville, USA Cryo–Cell Sourozenec 1999 University Medical Center, Tucson, USA CBR
Autologní 2007 Medical City Children´s Hospital, Dallas USA Cryo–Cell Sourozenec 2000 Children's Hospital of Orange County, USA ViaCord
Autologní 2007 Queen Mary Hospital, HongKong Progenics Cord Blood Cryobank Sourozenec 2000 Miami Children's Hospital, Miami, USA ViaCord
Autologní 2007 Starship Children´s Hospital, Auckland, Nový Zéland CordBank Sourozenec 2000 Duke University, Durham, USA ViaCord
C
Autologní 2009 Royal Children´s Hospital, Melbourne, Austrálie Cell Care Sourozenec 2000 Children's Memorial Hospital, Chicago, USA ViaCord
Sourozenec 2001 Hackensack University Medical Center, Hackensack, USA ViaCord
M
Retinoblastom Sourozenec 2002 Children's Hospital & Research Center Oakland, USA ViaCord
Y
Autologní 2001 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2002 University of Michigan, Ann Arbor, USA CBR
CM
MY
Autologní 2008 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2003 Children's Hospital & Research Center Oakland, USA ViaCord
CY
Sourozenec 2003 San Francisco General Hospital, San Francisco, USA ViaCord
Shwachman-Diamondův syndrom
CMY
Sourozenec 2004 All Children's Hospital, St. Petersburg, USA ViaCord
K
Autologní 2003 Children´s Hospital, Denver, USA FamilyCord Sourozenec 2004 Hackensack University Medical Center, Hackensack, USA ViaCord
Sourozenec 2006 Cincinnati Children's Hospital, Cincinnati, USA ViaCord Sourozenec 2004 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 2004 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Ewingův sarkom Sourozenec 2004 UCSF Medical Center, San Francisco, USA ViaCord
Autologní 2008 Hospital Durango, Mexico City, Mexiko Banco de Cordon Umbilical Sourozenec 2005 Duke University, Durham, USA ViaCord
Sourozenec 2005 Children's Hospital & Research Center Oakland, USA ViaCord
Neuronální nádor Sourozenec 2005 Children's Memorial Hospital, Chicago,USA ViaCord
Autologní 2008 Children´s Memorial Hospital, Chicago, USA ViaCord Sourozenec 2005 Children's Memorial Hospital, Chicago, USA ViaCord
Sourozenec 2005 Mattel Children’s Hospital, Los Angeles, USA CBR
Mozkový nádor Sourozenec 2005 University of Michigan, Ann Arbor, USA ViaCord
Autologní 2006 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2006 Hospital for Sick Children, Toronto, Kanada Insception Biosciences
Sourozenec 2006 Shands University of Florida, Gainesville, USA ViaCord
Autologní 2007 Miami Children´s Hospital, Miami, USA ViaCord
Sourozenec 2006 Hackensack University Medical Center, Hackensack, USA ViaCord
Sourozenec 2006 Siriraj Hospital, Bangkok, Thajsko Cryo–Cell
Diamond-Blackfanova anémie
Sourozenec 2007 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell
Sourozenec 1999 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2007 City of Hope, Duarte, USA ViaCord
Sourozenec 2001 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2007 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 2003 Dana–Farber Cancer Institute, Boston, USA ViaCord
Sourozenec 2007 Mount Elisabeth Hospital, Singapur Cryo–Cell
Sourozenec 2004 Hospital for Children, Wilmington, USA Cryo–Cell
Sourozenec 2007 Steriling Hospital, Ahmedabad, Indie Cryo–Cell
Sourozenec 2007 Schneider Children’s Hospital, New Hyde Park, USA CBR
www.cordbloodcenter.cz www.cordbloodcenter.cz
4 5
5. tabulka_A_2print 4-5.pdf 8/9/11 12:28:22 PM
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Myelodysplastický syndrom Fanconiho anémie
Autologní 2009 Chi Mei Medical Center, Tchaj-wan Bionet Sourozenec 1999 Johns Hopkins Hospital, Baltimore, USA ViaCord
Autologní 2010 University of Erlangen, Erlangen, Německo ViaCord Sourozenec 1999 University Medical Center, Tucson, USA CBR
Sourozenec 1995 University Medical Center, Tucson, USA CBR Sourozenec 2002 University of Minnesota, Minneapolis, USA ViaCord
Sourozenec 1999 Oregon Health & Science University, Portland, USA ViaCord Sourozenec 2003 Cincinnati Children's Hospital, Cincinnati, USA ViaCord
Sourozenec 2003 University of Mississippi, Jackson, USA ViaCord Sourozenec 2004 Children’s Hospital San Diego, San Diego, USA CBR
Sourozenec 2006 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2005 Cincinnati Children's Hospital, Cincinnati, USA ViaCord
Sourozenec 2006 Children's Hospital of Philadelphia, Philadelphia, USA ViaCord Sourozenec 2009 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Neuroblastom Beta-talasemie
Autologní 1998 Albert Einstein Hospital, Sao Paulo, Brazílie Albert Einstein Hospital Sourozenec 1998 University of Chicago, Chicago, USA ViaCord
Autologní 2001 Texas Children´s Hospital, Houston, USA ViaCord Sourozenec 1998 UCSF Medical Center, San Francisco, USA ViaCord
Autologní 2006 Vanderbilt University Medical Center Nashville, USA Cryo–Cell Sourozenec 1999 University Medical Center, Tucson, USA CBR
Autologní 2007 Medical City Children´s Hospital, Dallas USA Cryo–Cell Sourozenec 2000 Children's Hospital of Orange County, USA ViaCord
Autologní 2007 Queen Mary Hospital, HongKong Progenics Cord Blood Cryobank Sourozenec 2000 Miami Children's Hospital, Miami, USA ViaCord
Autologní 2007 Starship Children´s Hospital, Auckland, Nový Zéland CordBank Sourozenec 2000 Duke University, Durham, USA ViaCord
C
Autologní 2009 Royal Children´s Hospital, Melbourne, Austrálie Cell Care Sourozenec 2000 Children's Memorial Hospital, Chicago, USA ViaCord
Sourozenec 2001 Hackensack University Medical Center, Hackensack, USA ViaCord
M
Retinoblastom Sourozenec 2002 Children's Hospital & Research Center Oakland, USA ViaCord
Y
Autologní 2001 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2002 University of Michigan, Ann Arbor, USA CBR
CM
MY
Autologní 2008 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2003 Children's Hospital & Research Center Oakland, USA ViaCord
CY
Sourozenec 2003 San Francisco General Hospital, San Francisco, USA ViaCord
Shwachman-Diamondův syndrom
CMY
Sourozenec 2004 All Children's Hospital, St. Petersburg, USA ViaCord
K
Autologní 2003 Children´s Hospital, Denver, USA FamilyCord Sourozenec 2004 Hackensack University Medical Center, Hackensack, USA ViaCord
Sourozenec 2006 Cincinnati Children's Hospital, Cincinnati, USA ViaCord Sourozenec 2004 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 2004 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Ewingův sarkom Sourozenec 2004 UCSF Medical Center, San Francisco, USA ViaCord
Autologní 2008 Hospital Durango, Mexico City, Mexiko Banco de Cordon Umbilical Sourozenec 2005 Duke University, Durham, USA ViaCord
Sourozenec 2005 Children's Hospital & Research Center Oakland, USA ViaCord
Neuronální nádor Sourozenec 2005 Children's Memorial Hospital, Chicago,USA ViaCord
Autologní 2008 Children´s Memorial Hospital, Chicago, USA ViaCord Sourozenec 2005 Children's Memorial Hospital, Chicago, USA ViaCord
Sourozenec 2005 Mattel Children’s Hospital, Los Angeles, USA CBR
Mozkový nádor Sourozenec 2005 University of Michigan, Ann Arbor, USA ViaCord
Autologní 2006 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2006 Hospital for Sick Children, Toronto, Kanada Insception Biosciences
Sourozenec 2006 Shands University of Florida, Gainesville, USA ViaCord
Autologní 2007 Miami Children´s Hospital, Miami, USA ViaCord
Sourozenec 2006 Hackensack University Medical Center, Hackensack, USA ViaCord
Sourozenec 2006 Siriraj Hospital, Bangkok, Thajsko Cryo–Cell
Diamond-Blackfanova anémie
Sourozenec 2007 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell
Sourozenec 1999 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2007 City of Hope, Duarte, USA ViaCord
Sourozenec 2001 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2007 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 2003 Dana–Farber Cancer Institute, Boston, USA ViaCord
Sourozenec 2007 Mount Elisabeth Hospital, Singapur Cryo–Cell
Sourozenec 2004 Hospital for Children, Wilmington, USA Cryo–Cell
Sourozenec 2007 Steriling Hospital, Ahmedabad, Indie Cryo–Cell
Sourozenec 2007 Schneider Children’s Hospital, New Hyde Park, USA CBR
www.cordbloodcenter.cz www.cordbloodcenter.cz
4 5
6. tabulka_A_2print 6-7.pdf 8/9/11 12:29:36 PM
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Beta-talasemie/pokr. Srpkovitá anémie/pokr.
Sourozenec 2008 UCSF Medical Center, San Francisco, USA ViaCord Sourozenec 2009 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 2008 University of Michigan, Ann Arbor, USA ViaCord Sourozenec 2009 Children's National Medical Center, Washington, USA ViaCord
Sourozenec 2009 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell Sourozenec 2009 Medical University of South Carolina, Charleston, USA ViaCord
Sourozenec 2009 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell Sourozenec 2009 Miami Children's Hospital, Miami, USA ViaCord
Sourozenec 2009 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell Sourozenec 2009 Mt Sinai Medical Center, New York, USA ViaCord
Sourozenec 2009 Cook Children’s Medical Center, Ft. Worth, USA CBR Sourozenec 2010 Cook Children’s Medical Center, Ft. Worth, USA CBR
Sourozenec 2009 Texas Children’s Hospital, Houston, USA CBR Sourozenec 2010 Hackensack University Medical Center, USA CBR
Sourozenec 2009 Ulm, Německo Vita 34 Sourozenec 2010 Children's Hospital & Rearch Center Oakland, USA ViaCord
Sourozenec 2010 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2010 Miami Children's Hospital, Miami, USA ViaCord
Sourozenec 2010 Children's Hospital Medical Center, Cincinnatti, USA ViaCord Sourozenec 2010 Vanderbilt University Medical Center, Nashville, USA ViaCord
Srpkovitá anémie Syndrom Hurlerové
Sourozenec 1999 Hackensack University Medical Center, Hackensack USA ViaCord Sourozenec 2000 Children’s Medical Center of Dallas, Dallas, USA CBR
Sourozenec 2000 Lucile Packard Children's Hospital, Palo Alto, USA ViaCord Sourozenec 2003 University of Louisville, Louisville, USA ViaCord
Sourozenec 2000 St. Judes Children's Research Hospital, Memphis, USA ViaCord
Wolmanova choroba
C
Sourozenec 2000 University of North Carolina, Chapel Hill, ViaCord
M
Sourozenec 2001 Hackensack University Medical Center, Hackensack, USA ViaCord Sourozenec 2007 Children’s Hospital Los Angeles, Los Angeles, USA CBR
Y
Sourozenec 2001 University of Michigan, Ann Arbor, USA CBR
Sanfilippův syndrom
CM
Sourozenec 2001 University of Oklahoma, Oklahoma City, USA ViaCord
MY
Sourozenec 2002 Medical City Dallas, Dallas, USA CBR Sourozenec 2004 University Medical Center, Tucson, USA Cryo–Cell
CY
CMY
Sourozenec 2002 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Sourozenec 2002 Texas Transplant Institute, San Antonio, USA ViaCord T-lymfom
K
Sourozenec 2003 Medical University of South Carolina, Charleston, USA ViaCord Sourozenec 2002 All Children's Hospital, Florida, USA Cryo – Cell
Sourozenec 2004 New York–Presbyterian Hospital, New York, USA ViaCord
Sourozenec 2005 Children's Hospital & Research Center Oakland, USA ViaCord Adrenoleukodystrofie
Sourozenec 2005 University of Mississippi, Jackson, USA ViaCord Sourozenec 2003 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2005 University of Mississippi, Jackson, USA ViaCord Sourozenec 2005 Duke University, Durham, USA ViaCord
Sourozenec 2006 New York–Presbyterian Hospital, New York, USA ViaCord
Sourozenec 2006 Texas Children's Hospital, Houston, USA ViaCord Hypoplazie chrupavek a vlasů
Sourozenec 2006 Virginia Commonwealth University, Richmond, USA ViaCord Sourozenec 2010 Lucile Packard Children's Hospital, Palo Alto, USA ViaCord
Sourozenec 2007 Duke University, Durham, USA ViaCord
Sourozenec 2007 Children's Hospital of Philadelphia, Philadelphia, USA ViaCord Ektodermální dysplazie
Sourozenec 2007 Miami Children's Hospital, Miami, USA ViaCord Sourozenec 2004 Dana–Farber Cancer Institute, Boston, USA ViaCord
Sourozenec 2007 Mount Sinai Medical Center, New York, USA ViaCord
Sourozenec 2007 Nemours Children's Clinic, Jacksonville, USA ViaCord Chronická granulomatózní choroba
Sourozenec 2007 New York–Presbyterian Hospital, New York, USA ViaCord Sourozenec 2002 Hackensack University Medical Center, USA ViaCord
Sourozenec 2008 Children's Healthcare of Atlanta, Atlanta, USA ViaCord Sourozenec 2007 University of Rochester, Rochester, USA ViaCord
Sourozenec 2008 Methodist Children’s Hospital, San Antonio, USA CBR Sourozenec 2009 Texas Children's Hospital, Houston, USA ViaCord
Sourozenec 2008 North Shore Long Island Jewish Children's Hospital, USA Cryo–Cell
Sourozenec 2008 Schneider Children's Hospital, New Hyde Park, USA ViaCord Kostmannův syndrom
Sourozenec 2009 Dana–Farber Cancer Institute, Boston, USA ViaCord Sourozenec 2005 Children's Hospital of Pittsburg, Pittsburg, USA ViaCord
www.cordbloodcenter.cz www.cordbloodcenter.cz
6 7
7. tabulka_A_2print 6-7.pdf 8/9/11 12:29:36 PM
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Beta-talasemie/pokr. Srpkovitá anémie/pokr.
Sourozenec 2008 UCSF Medical Center, San Francisco, USA ViaCord Sourozenec 2009 Children's Hospital & Research Center Oakland, USA ViaCord
Sourozenec 2008 University of Michigan, Ann Arbor, USA ViaCord Sourozenec 2009 Children's National Medical Center, Washington, USA ViaCord
Sourozenec 2009 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell Sourozenec 2009 Medical University of South Carolina, Charleston, USA ViaCord
Sourozenec 2009 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell Sourozenec 2009 Miami Children's Hospital, Miami, USA ViaCord
Sourozenec 2009 Apollo Specialty Hospital, Chennai, Indie Cryo–Cell Sourozenec 2009 Mt Sinai Medical Center, New York, USA ViaCord
Sourozenec 2009 Cook Children’s Medical Center, Ft. Worth, USA CBR Sourozenec 2010 Cook Children’s Medical Center, Ft. Worth, USA CBR
Sourozenec 2009 Texas Children’s Hospital, Houston, USA CBR Sourozenec 2010 Hackensack University Medical Center, USA CBR
Sourozenec 2009 Ulm, Německo Vita 34 Sourozenec 2010 Children's Hospital & Rearch Center Oakland, USA ViaCord
Sourozenec 2010 Hospital for Sick Children, Toronto, Kanada Insception Biosciences Sourozenec 2010 Miami Children's Hospital, Miami, USA ViaCord
Sourozenec 2010 Children's Hospital Medical Center, Cincinnatti, USA ViaCord Sourozenec 2010 Vanderbilt University Medical Center, Nashville, USA ViaCord
Srpkovitá anémie Syndrom Hurlerové
Sourozenec 1999 Hackensack University Medical Center, Hackensack USA ViaCord Sourozenec 2000 Children’s Medical Center of Dallas, Dallas, USA CBR
Sourozenec 2000 Lucile Packard Children's Hospital, Palo Alto, USA ViaCord Sourozenec 2003 University of Louisville, Louisville, USA ViaCord
Sourozenec 2000 St. Judes Children's Research Hospital, Memphis, USA ViaCord
Wolmanova choroba
C
Sourozenec 2000 University of North Carolina, Chapel Hill, ViaCord
M
Sourozenec 2001 Hackensack University Medical Center, Hackensack, USA ViaCord Sourozenec 2007 Children’s Hospital Los Angeles, Los Angeles, USA CBR
Y
Sourozenec 2001 University of Michigan, Ann Arbor, USA CBR
Sanfilippův syndrom
CM
Sourozenec 2001 University of Oklahoma, Oklahoma City, USA ViaCord
MY
Sourozenec 2002 Medical City Dallas, Dallas, USA CBR Sourozenec 2004 University Medical Center, Tucson, USA Cryo–Cell
CY
CMY
Sourozenec 2002 Memorial Sloan–Kettering Cancer Center, New York, USA ViaCord
Sourozenec 2002 Texas Transplant Institute, San Antonio, USA ViaCord T-lymfom
K
Sourozenec 2003 Medical University of South Carolina, Charleston, USA ViaCord Sourozenec 2002 All Children's Hospital, Florida, USA Cryo – Cell
Sourozenec 2004 New York–Presbyterian Hospital, New York, USA ViaCord
Sourozenec 2005 Children's Hospital & Research Center Oakland, USA ViaCord Adrenoleukodystrofie
Sourozenec 2005 University of Mississippi, Jackson, USA ViaCord Sourozenec 2003 Detská fakultná nemocnica s poliklinikou, Bratislava, Slovensko CORD BLOOD CENTER Group
Sourozenec 2005 University of Mississippi, Jackson, USA ViaCord Sourozenec 2005 Duke University, Durham, USA ViaCord
Sourozenec 2006 New York–Presbyterian Hospital, New York, USA ViaCord
Sourozenec 2006 Texas Children's Hospital, Houston, USA ViaCord Hypoplazie chrupavek a vlasů
Sourozenec 2006 Virginia Commonwealth University, Richmond, USA ViaCord Sourozenec 2010 Lucile Packard Children's Hospital, Palo Alto, USA ViaCord
Sourozenec 2007 Duke University, Durham, USA ViaCord
Sourozenec 2007 Children's Hospital of Philadelphia, Philadelphia, USA ViaCord Ektodermální dysplazie
Sourozenec 2007 Miami Children's Hospital, Miami, USA ViaCord Sourozenec 2004 Dana–Farber Cancer Institute, Boston, USA ViaCord
Sourozenec 2007 Mount Sinai Medical Center, New York, USA ViaCord
Sourozenec 2007 Nemours Children's Clinic, Jacksonville, USA ViaCord Chronická granulomatózní choroba
Sourozenec 2007 New York–Presbyterian Hospital, New York, USA ViaCord Sourozenec 2002 Hackensack University Medical Center, USA ViaCord
Sourozenec 2008 Children's Healthcare of Atlanta, Atlanta, USA ViaCord Sourozenec 2007 University of Rochester, Rochester, USA ViaCord
Sourozenec 2008 Methodist Children’s Hospital, San Antonio, USA CBR Sourozenec 2009 Texas Children's Hospital, Houston, USA ViaCord
Sourozenec 2008 North Shore Long Island Jewish Children's Hospital, USA Cryo–Cell
Sourozenec 2008 Schneider Children's Hospital, New Hyde Park, USA ViaCord Kostmannův syndrom
Sourozenec 2009 Dana–Farber Cancer Institute, Boston, USA ViaCord Sourozenec 2005 Children's Hospital of Pittsburg, Pittsburg, USA ViaCord
www.cordbloodcenter.cz www.cordbloodcenter.cz
6 7
8. tabulka_A_2print 8.pdf 8/9/11 12:30:02 PM
Nemoc Dárce Rok Nemocnice Banka pupečníkové krve
Non-Hodgkinův lymfom
Sourozenec 2008 New York–Presbyterian Hospital, New York, USA ViaCord
X-vázaný lymfoproliferativní syndrom (Duncanova nemoc)
Sourozenec 2002 Fred Hutchinson Cancer Research Center, Seattle, USA ViaCord
Vrozená těžká neutropenie
Sourozenec 2007 Schneider Children's Hospital, New Hyde Park, USA ViaCord
Wiskott-Aldrichův syndrom
Sourozenec 1997 Fred Hutchinson Cancer Research Center, Seattle, USA ViaCord
Sourozenec 2003 Penn State Hershey Medical Center, Hershey, USA ViaCord
Těžká kombinovaná imunitní nedostatečnost
Sourozenec 2007 Cincinnati Children's Hospital, Cincinnati, USA ViaCord
C Vrozená imunitní nedostatečnost
M
Sourozenec 2007 EVROPA CryoSave
Y
CM
Vzácná porucha imunity
MY
Autologní 2007 Children's Memorial Hospital, Chicago, USA CBR
CY
CMY
K
Odkazy
www.cryo–cell.com/services/transplant_matrix.asp
www.cryo–save.com/int/#
www.ViaCord.com/service–expertise–transplant–history.htm
cordblood.net/pdf/transplant_summary.pdf
www.creativeconcept.sk 02.06.2011
www.parentsguidecordblood.org/content/usa/medical/autocbt.shtml?navid=38
Dr. Verter, Parent’s Guide to Cord Blood Foundation
(Rádce pro rodiče o fondu pupečníkové krve), osobní sdělení
www.cordbloodcenter.com/en/Corporate/CBC/Success–of–CBC–Group.alej
www.cordbloodcenter.cz
8